13.12.2012 Views

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

Bulletin 2009/07 - European Patent Office

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(C<strong>07</strong>D) I.1(1)<br />

WALLACE, Owen Brendan, Westfield, Indiana<br />

46<strong>07</strong>4, US<br />

XU, Yanping, Noblesville, Indiana 46062, US<br />

(74) Smith, Andrew George, Eli Lilly and Company<br />

Limited, Lilly Research Centre Erl Wood<br />

Manor Sunninghill Road Windlesham, Surrey<br />

GU20 6PH, GB<br />

(51) C<strong>07</strong>D 401/12 (11) 2 021 337 A2*<br />

C<strong>07</strong>D 2<strong>07</strong>/26 A61K 31/4015<br />

A61K 31/4025 A61P 3/10<br />

(25) En (26) En<br />

(21) <strong>07</strong>761186.1 (22) 24.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/067296 24.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/127726 20<strong>07</strong>/45 08.11.20<strong>07</strong><br />

(88) 03.01.2008<br />

(30) 25.04.2006 US 745569 P<br />

(54) • 11-BETA-HYDROXYSTEROID-DEHYDRO-<br />

GENASE-1-HEMMER<br />

• INHIBITORS OF 11-BETA-HYDROXYSTER-<br />

OID DEHYDROGENASE 1<br />

• INHIBITEURS DE LA 11-BETA-HYDRO-<br />

XYSTÉROÏDE DÉSHYDROGÉNASE 1<br />

(71) ELI LILLY AND COMPANY, Lilly Corporate<br />

Center, Indianapolis IN 46285, US<br />

(72) WALLACE, Owen, Brendan, Indiana 46<strong>07</strong>4,<br />

US<br />

LI, Renhua, Fishers, Indiana 46038, US<br />

MABRY, Thomas, Edward, Indianapolis,<br />

Indiana 46280, US<br />

WINNEROSKI, Leonard, Larry, Jr., Greenwood,<br />

Indiana 46142, US<br />

XU, Yanping, Noblesville, Indiana 46062, US<br />

(74) Smith, Andrew George, Eli Lilly and Company<br />

Limited, Lilly Research Centre Erl Wood<br />

Manor Sunninghill Road Windlesham, Surrey<br />

GU20 6PH, GB<br />

C<strong>07</strong>D 401/12 → (51) C<strong>07</strong>D 209/20<br />

C<strong>07</strong>D 401/12 → (51) C<strong>07</strong>D 233/90<br />

C<strong>07</strong>D 401/14 → (51) C<strong>07</strong>D 209/20<br />

C<strong>07</strong>D 401/14 → (51) C<strong>07</strong>D 401/12<br />

C<strong>07</strong>D 403/06 → (51) C<strong>07</strong>D 235/08<br />

C<strong>07</strong>D 403/12 → (51) C<strong>07</strong>D 209/20<br />

C<strong>07</strong>D 403/12 → (51) C<strong>07</strong>D 233/90<br />

C<strong>07</strong>D 403/12 → (51) C<strong>07</strong>D 401/12<br />

C<strong>07</strong>D 405/04 → (51) C<strong>07</strong>D 209/20<br />

C<strong>07</strong>D 405/04 → (51) C<strong>07</strong>D 213/64<br />

C<strong>07</strong>D 405/06 → (51) C<strong>07</strong>D 209/20<br />

C<strong>07</strong>D 405/12 → (51) C<strong>07</strong>D 309/38<br />

C<strong>07</strong>D 4<strong>07</strong>/12 → (51) C<strong>07</strong>D 213/64<br />

C<strong>07</strong>D 4<strong>07</strong>/12 → (51) C<strong>07</strong>D 233/90<br />

C<strong>07</strong>D 4<strong>07</strong>/12 → (51) C<strong>07</strong>D 309/38<br />

C<strong>07</strong>D 4<strong>07</strong>/12 → (51) C<strong>07</strong>D 401/12<br />

C<strong>07</strong>D 4<strong>07</strong>/14 → (51) C<strong>07</strong>D 401/12<br />

(51) C<strong>07</strong>D 413/04 (11) 2 021 338 A1*<br />

C<strong>07</strong>D 271/06 C<strong>07</strong>D 213/38<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

C<strong>07</strong>D 401/04 C<strong>07</strong>D 417/04<br />

C<strong>07</strong>D 271/10 A61P 35/00<br />

A61P 9/00 A61P 17/00<br />

A61P 19/00 A61P 25/00<br />

A61K 31/4245 A61K 31/4439<br />

A61K 31/506<br />

(25) En (26) En<br />

(21) <strong>07</strong>734443.0 (22) 26.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) IB 20<strong>07</strong>/001125 26.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/1323<strong>07</strong> 20<strong>07</strong>/47 22.11.20<strong>07</strong><br />

(30) 09.05.2006 US 799211 P<br />

(54) • CYCLOALKYLAMINOSÄUREDERIVATE<br />

UND PHARMAZEUTISCHE ZUSAMMEN-<br />

SETZUNG DAVON<br />

• CYCLOALKYLAMINO ACID DERIVATIVES<br />

AND PHARMACEUTICAL COMPOSITIONS<br />

THEREOF<br />

• DÉRIVÉS D'ACIDE CYCLOALKYLAMINÉ ET<br />

COMPOSITIONS PHARMACEUTIQUES À<br />

BASE DE CEUX-CI<br />

(71) Pfizer Products Inc., Eastern Point Road,<br />

Groton, CT 06340, US<br />

(72) BHATTACHARYA, Samit, Kumar Pfizer Global<br />

Research and Development, Groton, CT<br />

06340, US<br />

BROWN, Matthew, Frank Pfizer Global<br />

Research and Development, Groton, CT<br />

06340, US<br />

DORFF, Peter, Hans Pfizer Global Research<br />

and Development, Groton, CT 06340, US<br />

LAGRECA, Susan Pfizer Global Research and<br />

Development, Groton, CT 06340, US<br />

MAGUIRE, Robert, John Pfizer Global<br />

Research and Development, Groton, CT<br />

06340, US<br />

(74) Nevant, Marc, Pfizer <strong>European</strong> <strong>Patent</strong><br />

Department 23-25, avenue du Docteur<br />

Lannelongue, 75668 Paris Cedex 14, FR<br />

C<strong>07</strong>D 413/12 → (51) C<strong>07</strong>D 209/20<br />

C<strong>07</strong>D 413/12 → (51) C<strong>07</strong>D 213/64<br />

C<strong>07</strong>D 413/12 → (51) C<strong>07</strong>D 271/113<br />

C<strong>07</strong>D 417/04 → (51) C<strong>07</strong>D 209/20<br />

C<strong>07</strong>D 417/04 → (51) C<strong>07</strong>D 413/04<br />

(51) C<strong>07</strong>D 417/12 (11) 2 021 339 A1*<br />

A61K 31/427 A61P 3/10<br />

(25) En (26) En<br />

(21) <strong>07</strong>723463.1 (22) 21.03.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/002506 21.03.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/1<strong>07</strong>354 20<strong>07</strong>/39 27.09.20<strong>07</strong><br />

(30) 23.03.2006 EP 06005969<br />

(54) • ROSIGLITAZONHYDROCHLORID-HEMI-<br />

HYDRAT<br />

• ROSIGLITAZONE HYDROCHLORIDE<br />

HEMIHYDRATE<br />

• CHLORHYDRATE DE ROSIGLITAZONE<br />

HÉMIHYDRATÉ<br />

(71) SANDOZ AG, Lichtstrasse 35, 4056 Basel,<br />

CH<br />

(72) WIESER, Josef, A-6403 Polling, AT<br />

PICHLER, Arthur, A-6200 Jenbach, AT<br />

LENGAUER, Hannes, A-6250 Kundl, AT<br />

KLINGLER, Elfriede, A-6311 Wildschönau,<br />

AT<br />

86<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>07</strong>/<strong>2009</strong>) 11.02.<strong>2009</strong><br />

(74) Oser, Andreas, Prüfer & Partner GbR<br />

<strong>Patent</strong>anwälte Sohnckestrasse 12, 81479<br />

München, DE<br />

C<strong>07</strong>D 417/12 → (51) C<strong>07</strong>D 213/64<br />

C<strong>07</strong>D 417/12 → (51) C<strong>07</strong>D 401/12<br />

C<strong>07</strong>D 417/14 → (51) C<strong>07</strong>D 401/12<br />

(51) C<strong>07</strong>D 471/04 (11) 2 021 340 A2*<br />

(25) En (26) En<br />

(21) <strong>07</strong>797254.5 (22) 19.04.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) US 20<strong>07</strong>/066939 19.04.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/124345 20<strong>07</strong>/44 01.11.20<strong>07</strong><br />

(88) 27.03.2008<br />

(30) 21.04.2006 US 7938<strong>07</strong> P<br />

(54) • BETA-AMYLOID-PET-BILDGEBUNGSMIT-<br />

TEL<br />

• BETA-AMYLOID PET IMAGING AGENTS<br />

• AGENTS D'IMAGERIE TEP DE BÊTA-AMY-<br />

LOÏDES<br />

(71) The Government Of The United States, As<br />

Represented by The Secretary Of Health And<br />

Human Services, 6011 Executive Boulevard<br />

Suite 325, Rockville, Maryland 20852-3804,<br />

US<br />

(72) CAI, Lisheng, Derwood, Maryland 20855, US<br />

PIKE, Victor, W., Bethesda, Maryland 20852,<br />

US<br />

INNIS, Robert, B., Rockville, Maryland<br />

20850, US<br />

(74) Jacob, Reuben Ellis, et al, R G C Jenkins &<br />

Co. 26 Caxton Street, London SW1H 0RJ, GB<br />

C<strong>07</strong>D 471/08 → (51) C<strong>07</strong>D 271/113<br />

(51) C<strong>07</strong>D 471/14 (11) 2 021 341 A1*<br />

A61K 31/4985 A61P 25/18<br />

(25) En (26) En<br />

(21) <strong>07</strong>725638.6 (22) 29.05.20<strong>07</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

AL BA HR MK RS<br />

(86) EP 20<strong>07</strong>/004747 29.05.20<strong>07</strong><br />

(87) WO 20<strong>07</strong>/137819 20<strong>07</strong>/49 06.12.20<strong>07</strong><br />

(30) 30.05.2006 US 809251 P<br />

(54) • 4-AMINOPYRIDO[3,2-e]PYRAZINE, IHRE<br />

VERWENDUNG ALS INHIBITOREN VON<br />

PHOSPHODIESTERASE 10 UND VERFAH-<br />

REN ZU DEREN HERSTELLUNG<br />

• 4-AMINO-PYRIDOÝ3,2-e¨PYRAZINES,<br />

THEIR USE AS INHIBITORS OF PHOS-<br />

PHODIESTERASE 10, AND PROCESSES<br />

FOR PREPARING THEM<br />

• 4-AMINO-PYRIDOÝ3,2-e¨PYRAZINES,<br />

LEUR UTILISATION COMME INHIBITEURS<br />

DE LA PHOSPHODIESTÉRASE 10, ET<br />

LEURS MÉTHODES DE PRÉPARATION<br />

(71) Elbion Gmbh, Meissner Strasse 191, 01445<br />

Radebeul, DE<br />

(72) HÖFGEN, Norbert, 01458 Ottendorf-Okrilla,<br />

DE<br />

STANGE, Hans, 01587 Riesa, DE<br />

LANGEN, Barbara, 01445 Radebeul, DE<br />

EGERLAND, Ute, 01445 Radebeul, DE<br />

SCHINDLER, Rudolf, 01257 Dresden, DE<br />

GASPARIC, Antje, 01640 Coswig, DE<br />

RUNDFELDT, Chris, 01640 Coswig, DE<br />

(74) Weiss, Wolfgang, Weickmann & Weickmann<br />

<strong>Patent</strong>anwälte Postfach 86 08 20, 81635<br />

München, DE

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!